Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccsys Tech Regulatory News (AXS)

Share Price Information for Accsys Tech (AXS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 60.00
Bid: 60.00
Ask: 61.60
Change: -1.80 (-2.91%)
Spread: 1.60 (2.667%)
Open: 60.20
High: 60.20
Low: 60.00
Prev. Close: 61.80
AXS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

30 Apr 2009 07:00

RNS Number : 3914R
Accsys Technologies PLC
30 April 2009
 



30th April 2009 AIM: AXS

NYSE Euronext Amsterdam: AXS

Accsys Technologies PLC

Directorate changes

Accsys Technologies PLC (the "Company") announces the appointment of Paul Hugh Anthony Clegg to the Board with effect from 29 April 2009. Paul Clegg, aged 48, has joined the Board as a non-executive director.

Paul was previously Managing Director and Chief Executive Officer of Cowen International Limited and director of Cowen Asset Management Limited until June 2008 and is currently a director of Clegg Enterprises Limited. Paul brings over twenty years' senior investment banking experience to the Company.

In accordance with the AIM Rules for Companies, the Company confirms that there is no further disclosure obligation required, pursuant to Rule 17, Schedule Two, Paragraph (g).

ENDS

For further information, please contact:

Accsys Technologies PLC

William Paterson-Brown,

Executive Chairman 

+44 20 8150 8835

Matrix Corporate Capital LLP

Threadneedle 

Communications

Stephen Mischler

Anu Tayal

Graham Herring

Josh Royston

graham.herring@threadneedlepr.co.uk

josh.royston@threadneedlepr.co.uk

+44 20 3206 7000

+44 20 7653 9850

Citigate First Financial B.V.

Wouter van de Putte 

Laurens Goverse 

+ 31 20 575 4080

Notes to Editors: 

Accsys Technologies PLC (www.accsysplc.com) is an environmental science and technology company whose primary focus is on the production of Accoya® wood and technology licensing via its 100% owned subsidiary, Titan Wood Limited (www.titanwood.com), which has manufacturing operations in Arnhem, the Netherlands, a European office in London and an Americas office in Dallas, Texas. Accsys' operations comprise three principal business units: (i) the Accoya® wood production facility located in Arnhem, The Netherlands; (ii) technology development, focused on a programme of continuous improvements to the process engineering and operating protocols for the acetylation of wood which are currently under development and the development of technology for the acetylation of wood fibre; and (iii) the licensing of technology for the production of Accoya® wood and Tricoya™ wood elements across the globe.

Accoya® Wood (www.accoya.info) is produced by using a patented, non-toxic process that effectively converts sustainably grown softwoods and non-durable hardwoods into what is best described as a "new wood species" via acetylation. Distinguished by its durability, dimensional stability and, perhaps most importantly of all, its reliability (in terms of consistency of both supply and quality), Accoya® wood is particularly suited to exterior applications where performance and appearance are valued. Unlike most woods, its colour does not degrade when exposed to sunlight. Moreover, the Accoya® wood production process does not compromise the wood's strength or machinability. The combination of UV resistance, dimensional stability, increased coatings life, durability and retained strength means that Accoya® wood offers a wealth of new opportunities to architects, designers and specifiers. Leading applications include external doors and windows, shutters/shading, siding and cladding, decking, outdoor furniture/equipment and glulam beams for structural use. 

Tricoya™ Wood Elements (www.tricoya.com) is Titan Wood's proprietary technology for the acetylation of wood fibres, chips, and particles for use in the fabrication of wood based composites, including panel products. These composites demonstrate enhanced durability and dimensional stability which allow them to be used in a variety of applications which were once limited to solid wood or man-made products. Tricoya™ Wood Elements is lauded as the first major innovation in the wood composites industry in more than 30 years.

Wood Acetylation is a process, which increases the amount of 'acetyl' molecules in wood, thereby changing its physical properties. The environmentally responsible process protects wood from rot by making it "inedible" to most micro-organisms and insects, without - unlike conventional treatments - making it toxic. It also greatly reduces the wood's tendency to swell and shrink, making it less prone to cracking and ensuring that when painted it requires dramatically reduced maintenance. Acetylated wood's increased durability offers major carbon sequestration advantages, compared to other woods and man-made building materials such as steel, vinyl, and plastic.

Wood Composites include a range of derivative wood products which are manufactured by binding together the strands, particles, fibres, or veneers of wood, together with adhesives, to form composite materials. These products are engineered to precise design specifications which are tested to meet national or international standards.

ACCOYA® and the Trimarque logo are registered trademarks owned by Titan Wood Limited. TRICOYA™ and the Elements logo are trademarks owned by Titan Wood Limited. These may not be used or reproduced without written permission.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAGGGZDDLMGLZM
Date   Source Headline
24th Jun 20087:00 amRNSDividend Declaration
19th Jun 20087:55 amRNSDirectorate Change
19th Jun 20087:00 amRNSFinal Results
12th May 20081:45 pmRNSBoard Change & Directors' Dea
1st Apr 20087:00 amRNSInnovation & Eco Awards Won
31st Mar 20087:00 amRNSDirector's Interests
28th Mar 20087:01 amRNSDirector's Interests
25th Mar 20087:01 amRNSFull License Agreement
14th Mar 20087:00 amRNSNotifiable Interest
12th Mar 20083:16 pmRNSHolding(s) in Company
11th Mar 20087:00 amRNSNorwegian Agency Agreement
12th Feb 20087:00 amRNSQuarterly Performance Update
31st Jan 20087:01 amRNSTotal Voting Rights
10th Jan 200812:05 pmRNSAdditional Listing
11th Dec 20077:01 amRNSUAE Rights & Expand Capacity
21st Nov 20077:01 amRNSInterim Results
20th Nov 20077:15 amRNSChina License Agreement
20th Nov 20077:01 amRNSNew Business Relationship
15th Oct 20077:00 amRNSLicense Option Agreement
11th Oct 20074:19 pmRNSDirector/PDMR Shareholding
11th Oct 20072:00 pmRNSDirector/PDMR Shareholding
11th Oct 20077:00 amRNSAppointment of new CEO
28th Sep 20077:00 amRNSTotal Voting Rights
26th Sep 20077:01 amRNSDirector's Interests
18th Sep 20077:02 amRNSEuronext Amsterdam Admission
13th Sep 20072:53 pmRNSSUPPLEMENTARY PROSPECTUS
5th Sep 20077:01 amRNSAdditional Listing
4th Sep 20077:02 amRNSProposed Listing
3rd Sep 20077:01 amRNSChina Option Agreement
20th Aug 20077:00 amRNSLISTING ON EURONEXT AMSTERDAM
17th Aug 20077:00 amRNSNew Appointment
16th Aug 20077:00 amRNSHolding(s) in Company
2nd Aug 20076:05 pmRNSTotal Voting Rights
27th Jul 200710:00 amRNSAdditional Listing
28th Jun 20077:01 amRNSPRELIMINARY RESULTS
25th Jun 20077:02 amRNSAgreement
21st Jun 20074:59 pmRNSHolding(s) in Company
4th Jun 20077:01 amRNSHolding(s) in Company
31st May 20077:01 amRNSTotal Voting Rights
24th May 20072:07 pmRNSHolding(s) in Company
23rd May 20079:14 amRNSAppointment
21st May 200711:49 amRNSCompletion of Subscription
16th May 20077:01 amRNSDirectors Options
15th May 20073:19 pmRNSEGM Statement
30th Apr 20072:13 pmRNSTotal Voting Rights
24th Apr 20077:01 amRNSDirector/Notifiable Interests
11th Apr 20077:01 amRNSPosting of circular
2nd Apr 20077:00 amRNSDirector/PDMR Shareholding
28th Mar 20072:18 pmBUSCelanese Corporation Announces Strategic Partnership with Accsys Technologies for Innovative Use of Acetyl Products
28th Mar 20077:04 amRNSStrategic Partnership

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.